C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/18 (2006.01) A61K 49/00 (2006.01) C07K 16/46 (2006.01) G01N 33/15 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) C12N 15/09 (2006.01)
Patent
CA 2728473
Among antibodies which are usable for immunostaining arteriosclerosis sections, an antibody applicable to in vivo imaging is identified and the specificity thereof is analyzed. As a result, it is clarified that a fluorescent labeled product of the anti-LDL/.beta.2GPI complex antibody having a specificity to a specific epitope is efficacious in the imaging.
Linvention concerne lidentification dun anticorps applicable à limagerie in vivo parmi les anticorps utilisables pour limmunocoloration de sections dartériosclérose et lanalyse de sa spécificité. Par conséquent, on constate quun produit marqué par fluorescence de lanticorps dirigé contre le complexe LDL/ß2GPI présentant une spécificité poue un épitope spécifique est efficace dans limagerie.
Kojima Kazuo
Matsuura Eiji
Medical And Biological Laboratories Co. Ltd.
National University Corporation Okayama University
Smart & Biggar
LandOfFree
Antibody against oxidized ldl/.beta.2gpi complex and use of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody against oxidized ldl/.beta.2gpi complex and use of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody against oxidized ldl/.beta.2gpi complex and use of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1983203